# EDGAR Filing Document

**Accession Number:** 0000711377
**File Stem:** 0001140361-25-044419
**Filing Date:** 2025-12
**Character Count:** 11357
**Document Hash:** db705bd5964ba55b16d511091034d6e9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-25-044419.hdr.sgml**: 20251204

**ACCESSION NUMBER**: 0001140361-25-044419

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251204

**DATE AS OF CHANGE**: 20251204

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NEOGEN CORP
- **CENTRAL INDEX KEY:** 0000711377
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 382367843
- **STATE OF INCORPORATION:** MI
- **FISCAL YEAR END:** 0531

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-40503
- **FILM NUMBER:** 251551061

**BUSINESS ADDRESS:**
- **STREET 1:** 620 LESHER PLACE
- **CITY:** LANSING
- **STATE:** MI
- **ZIP:** 48912
- **BUSINESS PHONE:** 5173729200

**MAIL ADDRESS:**
- **STREET 1:** 620 LESHER PLACE
- **CITY:** LANSING
- **STATE:** MI
- **ZIP:** 48912
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ING GROEP NV
- **CENTRAL INDEX KEY:** 0001039765
- **STANDARD INDUSTRIAL CLASSIFICATION:** COMMERCIAL BANKS, NEC [6029]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000
- **STATE OF INCORPORATION:** P7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** PO BOX 1800
- **CITY:** AMSTERDAM
- **STATE:** P7
- **ZIP:** 1000 BV
- **BUSINESS PHONE:** 01131205639111

**MAIL ADDRESS:**
- **STREET 1:** PO BOX 1800
- **CITY:** AMSTERDAM
- **STATE:** P7
- **ZIP:** 1000 BV

## Ex-99.A

#### Exhibit A to Schedule 13G
Joint Filing Agreement

Pursuant to Rule 13d-1(k)

The undersigned persons (the "**Reporting Persons**") hereby agree that a joint statement on this Schedule 13G be filed on their behalf by ING Groep N.V.

Each of the Reporting Persons is responsible for the completeness and accuracy of the information concerning each of them contained therein, but none of the Reporting Persons is responsible for the completeness or accuracy of the information concerning any other Reporting Person.

---

| | | |
|:---|:---|:---|
| Dated: December 4, 2025 |  |  |
|  | ING GROEP N.V. | ING GROEP N.V. |
|  | By: | /s/ R. Loof |
|  | Name: | R. Loof |
|  | Title: | Compliance Officer |
|  | By: | /s/ J.A.M. Emke-Petrelluzzi Bojanic |
|  | Name: | J.A.M. Emke-Petrelluzzi Bojanic |
|  | Title: | Sr. Compliance Officer |
|  | ING CAPITAL MARKETS LLC | ING CAPITAL MARKETS LLC |
|  | By: | /s/ Tim Casady |
|  | Name: | Tim Casady |
|  | Title: | Authorized Person |

---

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Issuer:** NEOGEN CORP

**Title of Class of Securities:** Common Stock, $0.16 par value per share

**CUSIP Number:** 640491106

**Date of Event Which Requires Filing of this Statement:** 11/28/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>ING GROEP NV | Names of Reporting Persons<br>ING GROEP NV |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>P7 | Citizenship or Place of Organization<br>P7 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>8673700 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>8673700 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>8673700 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>8673700 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>3.99% | Percent of Class Represented by Amount in Row (9)<br>3.99% |
| 12. | Type of Reporting Person (See Instructions)<br>HC | Type of Reporting Person (See Instructions)<br>HC |

**Comment for Type of Reporting Person:** * Based on the 217,298,626 shares of common stock of the issuer (the "Common Stock") as of August 31, 2025, as reported in the issuer's Quarterly Report on Form 10-Q for the period ended in August 31, 2025, filed with the Securities and Exchange Commission on October 9, 2025.

---

| 1. | Names of Reporting Persons<br>ING Capital Markets LLC | Names of Reporting Persons<br>ING Capital Markets LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>8673700 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>8673700 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>8673700 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>8673700 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>3.99% | Percent of Class Represented by Amount in Row (9)<br>3.99% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** * Based on the 217,298,626 shares of common stock of the issuer (the "Common Stock") as of August 31, 2025, as reported in the issuer's Quarterly Report on Form 10-Q for the period ended in August 31, 2025, filed with the Securities and Exchange Commission on October 9, 2025.

---

**Item 1(a). Name of Issuer:**
NEOGEN CORP

**Item 1(b). Address of Issuer's Principal Executive Offices:**
620 Lesher Place, Lansing, Michigan, 48912

**Item 2(a). Name of Person Filing:**
ING Groep, N.V. 
ING Capital Markets LLC

**Item 2(b). Address of Principal Business Office:**
ING Groep N.V.
PO Box 1800
Amsterdam, P7 
1000 BV Amsterdam

ING Capital Markets LLC 
1133 Avenue of the Americas
New York, NY 10036 
USA

**Item 2(c). Citizenship:**
ING Groep N.V. - The Netherlands
ING Capital Markets LLC - Delaware

**Item 2(d). Title of Class of Securities:**
Common Stock, $0.16 par value per share

**Item 2(e). CUSIP Number:**
640491106

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

ING Groep N.V. may be deemed to be the beneficial owner of 8,673,700 Common Stock, held by ING Capital Markets LLC, a wholly owned subsidiary of ING Groep N.V. ING Capital Markets LLC may be deemed to be the beneficial owner of 8,673,700 Common Stock.

**(b) Percent of class:**

Each of ING Groep N.V. and ING Capital Markets LLC may be deemed to be the beneficial owner of approximately 3.99% of Common Stock issued and outstanding as of August 31, 2025, as reported in the issuer's Quarterly Report on Form 10-Q for the period ended in August 31, 2025, filed with the Securities and Exchange Commission on October 9, 2025.

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

0

**(ii) Shared power to vote or to direct the vote:**

8,673,700

**(iii) Sole power to dispose or to direct the disposition of:**

0

**(iv) Shared power to dispose or to direct the disposition of:**

8,673,700

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**ING GROEP NV**

**Date:** 12/04/2025

**By:** /s/ R. Loof

**Name & Title:** R. Loof, Compliance Officer

**ING Capital Markets LLC**

**Date:** 12/04/2025

**By:** /s/ Tim Casady

**Name & Title:** Tim Casady, Authorized Person